https://www.selleckchem.com/pr....oducts/seclidemstat.
2%). The non-response rate was 5.1% once the effect of low adherence was minimised. For the 1376 drop instillation days under observation, eye drops were instilled as prescribed on 1004 days (73.0%), over-instilled on 137 days (9.9%) and not instilled on 235 days (17.1%). The Cardiff Model of Glaucoma Care involved negligible cost, although acceptance for healthcare professionals showed variation. CONCLUSIONS The Cardiff Model of Glaucoma Care offers novel clinical and adherence insights at marginal costs while acceptable to patien